Brief Communication of Assessment of Clinical Practice Regarding Pharmacological Treatment of Epilepsy: A Survey of Neurologists in Republic of Macedonia
References
- 1. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. http://www.ibe-epilepsy.org/downloads/EURO%20 Report%20160510.pdf
- 2. Malmgren K, Flink R, Guekht AB, et al. ILAE Commission of European Affairs Subcommission on European Guidelines 1998-2001: The provision of epilepsy care across Europe. Epilepsia. 2003; 44(5): 727-731.10.1046/j.1528-1157.2003.58402.x
- 3. Wiebe S, Tellez-Zenteno J, Shapiro M. An evidencebased approach to the first seizure Epilepsia. 2008; 49 (Suppl. 1): 50-57.10.1111/j.1528-1167.2008.01451.x
- 4. Marson A. When to start antiepileptic drug treatment and with what evidence? Epilepsia. 2008; 49 (Suppl. 1): 3-6.10.1111/j.1528-1167.2008.01920.x
- 5. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011; 10: 446-56.10.1016/S1474-4422(11)70047-3
- 6. Hixson J. Stopping Antiepileptic Drugs: When and Why? Current Treatment Options in Neurology. 2010; 12: 434-442.
- 7. Camfield P, Camfield C. When is it safe to discontinue AED treatment? Epilepsia. 2008; 49 (Suppl. 9): 25-28.10.1111/j.1528-1167.2008.01923.x
- 8. Glauser T, Ben-Menachem E, Bourgeoiset B, et al. ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes. Epilepsia. 2006; 47(7): 1094-1120.10.1111/j.1528-1167.2006.00585.x
- 9. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Societ Neurology. 2004; 62: 1252-1260.
- 10. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
- 11. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (update). (Clinical guideline 137.)
- 2012. http://guidance.nice.org.uk/CG137.
- 12. Beydoun A, D'Souza J. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert Opin Pharmacother. 2012; 13(9): 1283-98.10.1517/14656566.2012.685162
- 13. Bourgeois BF. Chronic management of seizures in the syndrom es of idiopathic generalized epilepsy. Epilepsia. 2003; 44 Suppl 2: 27-32.10.1046/j.1528-1157.44.s.2.1.x
- 14. S. Noachtar, E. Andermann, P. Meyvisch, F. Andermann, W. B. Gough, J. Schiemann-Delgado, Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures Neurology. 2008; 70(8): 607-616.
- 15. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16, 2002; 695-714.10.2165/00023210-200216100-00004
- 16. Marson A.G, Al-Kharusi A.M, Alwaidh M, Appleton R, Baker G.A, et al. SANAD Study group, 2007. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 369, 1016-1026.10.1016/S0140-6736(07)60461-9
- 17. Gelisse P, Genton P, Kuate C, Pesenti A, Baldy- Moulinier M, Crespel A. Worsening of Seizures by Oxcarbazepine in Juvenile Idiopathic Generalized Epilepsies. Epilepsia. 2004; 45: 1282-1286. 1. 1.10.1111/j.0013-9580.2004.19704.x15461683
- 18. Thomas P, Valton L and Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006; 129, 1281-1292.
- 19. Lige Liu, Thomas Zheng, Margaret J. Morris, Charlott Wallengren, Alison L. Clarke, Christopher A. Reid, et al. The Mechanism of Carbamazepine Aggravation of Absence Seizures. The Journal of Pharmacology and Experimental Therapeutics. 2006; 319: 790-798.10.1124/jpet.106.10496816895979
Language: English
Page range: 163 - 166
Published on: Mar 1, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Related subjects:
© 2015 Emilija Cvetkovska, Igor Kuzmanovski, Bojan Boshkovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.